Single cEll pRofiling PErsistaNce To ImmuNothErapy

Clinical trial NCT06680739 · RECRUITING

Trial details

NCT number: NCT06680739
Sponsor: Vall d'Hebron Institute of Oncology
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Endometrial Cancer

Start date: 2022-03-01
Primary completion: 2032-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.